Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Opioids are group of analgesic agents which are commonly used in clinical practice. These are further classified according to their effect at opioid receptor. The opioids have three classical opioid receptors (DOP, KOP and MOP), while the novel NOP receptor is considered to be a non-opioid branch of the opioid receptor family. The advances in pharmacotherapy of chronic pain have led to the development of extended-release opioid delivery systems, thereby allowing less frequent dosing than the classic short-acting formulas. These opioids are in different dosage form by routes of administration, including oral, transdermal, intramuscular, intravenous and others. Moreover, the immune system and its relationship to opioid function is one such emergent area as it has been known for their ability to suppress acute pain, in area of chronic pain.
The key factor driving the growth of global opioids market is increase in incidence of orthopedic diseases & chronic pain due to disease and increasing road accidents which is fueling the growth for opioids market. Beside rise in disposable income is due to cost-effective solution for patients suffering from low back pain, cancer pain and others which is further fueling the growth of market. Also, surge in global geriatric population and need for proper medicated pain suppressing products is further driving the growth of market.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the opioids market. In addition, complete analysis of changes on the opioids market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. COVID-19 impact on the opioids market
The opioids market is segmented based on by product, by application and geography
The opioids market are available by different product types including codeine, fentanyl, hydrocodone, methadone, morphine and oxycodone
Oxycodone is expected to lead in the global opioids market owing to increasing consumption to relieve moderate to severe pain. This oxycodone is an effective analgesic for many types of pain, and is especially useful for paroxysmal spontaneous pain, steady pain, allodynia associated with postherpetic neuralgia, and it is also increasingly used in the management of cancer-related and chronic pain, oxycodone has been found to improve the quality of life of patients with many types of pain. Beside fentanyl is anticipated to be the fastest growing due to its usage in various formulations including solutions for injection in multiple concentrations for acute pain management and anesthesia and as oral tablets & lozenges, transdermal patches and nasal sprays for treating of chronic pain.
The opioids market has its major application in pain management, cough treatment, diarrhea treatment
Pain management is further bifurcated to cancer pain, postoperative pain management, low-back pain, orthopedic, neuropathic pain and fibromyalgia. Pain management dominated the global opioid market due to globe usage for pain management ranging from mild to severe pain.
Geographically the global opioids market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW)
North America is anticipated to lead in the global opioids market holding significant market share. However likely to witness a decline in its market share owing to rising government initiatives. Whereas Europe is expected to growth at a significant rate during the forecast period due to growing healthcare facilities. However, Asia Pacific is estimated to witness the fastest growth during the forecast period. The increasing population and availability of effective opioid medications are likely to be the key factors for the growth of the region. Beside countries in Asia Pacific is expected to hold significant share in global opioids market. Moreover, increasing number of opioid manufacturers is further propelling the regional growth
The key players in opioids market are Pfizer, Inc. , Purdue Pharma, Sanofi, Sun Pharmaceuticals, Taj Pharmaceuticals Limited, Alcaliber S.A., Manus Aktteva, McKesson Corporation, Northeast Pharmaceutical Group Co., Ltd ( NEPG ), Verve Health, West-Ward Pharmaceuticals Corporation, Allergan, Plc, Boehringer Ingelheim, Egalet Corporation, Endo Pharmaceuticals Inc., Endo Pharmaceuticals Inc., J M Smith Corporation, Janssen Pharmaceuticals, Inc., Johnson Matthey, Mallinckrodt Pharmaceuticals and Par Pharmaceutical among others.
The report analyses the global opioids market based on by product, by application and geography. The opioids market are available by different product types including codeine, fentanyl, hydrocodone, methadone, morphine and oxycodone. The opioids market has its major application in pain management, cough treatment, diarrhea treatment. Geographically the global opioids market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW)
The key players in opioids market are Pfizer, Inc. , Purdue Pharma, Sanofi, Sun Pharmaceuticals, Taj Pharmaceuticals Limited, Alcaliber S.A., Manus Aktteva, McKesson Corporation, Northeast Pharmaceutical Group Co., Ltd ( NEPG ), Verve Health, West-Ward Pharmaceuticals Corporation, Allergan, Plc, Boehringer Ingelheim, Egalet Corporation, Endo Pharmaceuticals Inc., Endo Pharmaceuticals Inc., J M Smith Corporation, Janssen Pharmaceuticals, Inc., Johnson Matthey, Mallinckrodt Pharmaceuticals and Par Pharmaceutical among others.
Why to buy this report:
